Evidence map›Paper›PMID 26111861›Full record

ArticleJournal of assisted reproduction and genetics2015

Birth of nine normal healthy babies following transfer of blastocysts derived from human single-pronucleate zygotes.

Fumiaki Itoi, Yukiko Asano, Masashi Shimizu, Hiroyuki Honnma, Yasutaka Murata

Abstract read
In one paragraph

Article in Journal of assisted reproduction and genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Could blastocysts derived from abnormal fertilized zygotes be used? A systematic review and meta-analysis.European journal of obstetrics & gynecology and reproductive biology: X · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Assessing the clinical viability of micro 3 pronuclei zygotes.Journal of assisted reproduction and genetics · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Cell number considerations for blastocyst transfer in younger patients.Journal of assisted reproduction and genetics · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Fumiaki ItoiDepartment of Infertility, Green Bell Clinic, Kitamachi 2-160, Toyota, Aichi, 471-0027, Japan. fumiaki-itoi@kishokai.or.jp.
Yukiko AsanoDepartment of Infertility, Royal Bell Clinic, Mizuhiro 1-17-15, Narumicho, Midori-ku, Nagoya, Aichi, 458-0801, Japan. yukiko-nagashima@kishokai.or.jp.
Masashi ShimizuDepartment of Infertility, Angel Bell Hospital, Nishiki-cho 5-1, Okazaki, Aichi, 444-0067, Japan. masashi-shimizu@kishokai.or.jp.
Hiroyuki HonnmaSapporo ART Clinic, Kita7jonishi 4-1-2, Kita-ku, Sapporo, Hokkaido, 060-0807, Japan. honma47@yahoo.co.jp.
Yasutaka MurataDepartment of Infertility, Angel Bell Hospital, Nishiki-cho 5-1, Okazaki, Aichi, 444-0067, Japan. murata@kishokai.or.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe purpose of this study is to examine the clinical outcomes of blastocysts derived from human single-pronucleate (1PN) embryos after conventional in vitro fertilization (cIVF) and intracytoplasmic sperm injection (ICSI) cycles.

methodsThis was a retrospective study at a reproductive center of a hospital. To evaluate embryo quality and clinical outcomes, cIVF or ICSI cycles with one or more 1PN embryos were compared with same cycles with 2PN embryos (control cycles).

resultsA total of 623 cycles (426 cIVF cycles and 197 ICSI cycles) were treated with cIVF or ICSI. The single pronuclear status rate was similar between cIVF (22.1 %) and ICSI (25.1 %) cycles. Although the development rates of 1PN embryos on day 3 and day 5/6 in cIVF were significantly higher than those in ICSI, those of 1PN embryos in cIVF were significantly lower compared to 2PN embryos (p < 0.01). Nonetheless, the ongoing pregnancy rates achieved with 1PN blastocysts in 1PN embryos did not significantly differ from the control group. Thirty-three transfer cycles with 33 blastocysts derived from 1PN embryos in cIVF resulted in nine deliveries with no newborn malformations; however, no implantation was observed in three ICSI cycles.

conclusionAlthough the blastocyst formation rate of 1PN embryos was significantly lower than 2PN embryos in cIVF and ICSI cycles, 1PN blastocysts in cIVF, and not from ICSI, demonstrated an adequate ongoing pregnancy rate. These results suggested that 1PN blastocysts in cIVF are available for clinical use and may lead to an increase in the chance of pregnancy in patients receiving assisted reproductive technology with 1PN embryos.

Indexed as

Embryo ImplantationAdultBlastocystCell NucleusEmbryo, MammalianEmbryonic DevelopmentEmbryo TransferFemaleFertilization in VitroFollow-Up StudiesHumansOocytesPregnancyPrognosisRetrospective StudiesZygoteBlastocyst cultureClinical outcomeConventional in vitro fertilizationIntracytoplasmic sperm injectionNormal healthy babiesSingle-pronucleate embryos

Identifiers

PMID26111861
PMCPMC4595390

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.